27 May 2013 - Deborah Wilkes
Archived
Valeant Pharmaceuticals International looks set to acquire the eye health specialist Bausch + Lomb from Warburg Pincus for US$8.7 billion in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.